BNVA 150 (Boniva 150 mg)
Generic Name: ibandronate
Pill imprint BNVA 150 has been identified as Boniva 150 mg.
Boniva is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ibandronate
- Imprint:
- BNVA 150
- Strength:
- 150 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0186
- Inactive Ingredients:
- lactose monohydrate
povidone k25
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5322 | Physicians Total Care Inc (repackager) |
| 35356-0423 | Lake Erie Medical and Surgical Supply (repackager) |
| 16590-0400 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
More about Boniva (ibandronate)
Consumer resources
- Boniva
- Boniva IV Injection
- Boniva injection
- Boniva oral/injection
- Boniva (Advanced Reading)
- Boniva Intravenous (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
